New York · Nonprofit
AIDS VACCINE ADVOCACY COALITION INC
AIDS VACCINE ADVOCACY COALITION INC (New York) receives grants from 16 organizations whose IRS filings report $72,547,415 to it, the largest being GATES FOUNDATION ($63,807,563). 11 of them have funded it in more than one year.
- Revenue FY2024
- $10M
- Funders on record
- 16
- Grants received
- $73M
- Net assets
- $3.0M
What AIDS Vaccine Advocacy Coalition Inc does
Mission
Accelerate the ethical development of effective hiv prevention options and ensure access to those options for everyone who needs them as part of a comprehensive integrated path to global health equity.
As stated on its FY2024 Form 990.
Programs
Research engagement and preparedness: research preparedness is designed to shape the r&d environment through advocacy for investment, political support, and good participatory practice. Avac tracks and translates both community advocacy and complex science to make the science accessible and position community priorities at the center of global health. Avac improved trial design and conduct by bringing together researchers, trial site staff, civil society, policymakers, trial participants, and communities to center perspectives of affected communities in research. Avac developed materials and documents relating to the prevention of hiv/aids; convened multiple meetings with stakeholders such as researchers and civil society leaders to discuss research findings; program service accomplishments.
$4,270,402 spentof which $1,970,965 as grants35% of program spendingPolicy advocacy: avac works with partners and policymakers to develop and pursue national, regional, and international agendas that advance hiv prevention and global health equity and lay a foundation for global health security against future pandemics. Avac helps shape global health spending and planning for hiv prevention by mobilizing to ensure programs, products and policies are evidence-based, inclusive and effective. With a network of partners, avac identifies policy needs and develops campaigns to advance hiv prevention with a focus on ensuring rich, community-supported advocacy networks and major africa-led initatives to call for choice and equity in hiv prevention investments globally; and issued subgrants to more than 13 partners in the us and africa (continued on schedule o)continued: under the hiv biomedical prevention research project funded by usaid to identify and mitigate or eliminate barriers to the development of and access to new hiv vaccines and other prevention options; and promote increased resources for hiv vaccine and prevention research by donors including government agencies.
$3,278,560 spentof which $1,704,086 as grants27% of program spendingGlobal movement building: global movement building cultivates the next generation of advocates via the avac fellows and advocacy navigator programs. Advocates are equipped with the skills, opportunities and access to drive change in hiv prevention and global health equity by amplifying community voices and influencing policy and research. Alumni of these programs are leading, internationally recognized civil society advocates. They have gone on to found civil society organizations, influence the hiv prevention research pipeline, and shape conversations and objectives in the field. Avac also shapes the media environment by collaborating closely with journalist conveners to bring together journalists and scientists at media science cafes. Through this engagement with experts, (continued on schedule o)continued: local journalists have direct access to accurate data and information, enabling them to translate the science and report directly to local communities on developments in hiv biomedical prevention research. This improves the quality and accuracy of reporting, combats misinformation, and brings visibility to research developments.
$1,604,969 spentof which $495,934 as grants13% of program spendingPrograms are product introduction and access and program management and communications.
$3,075,521 spentof which $209,211 as grants25% of program spending
The 4 programs described on its FY2023 Form 990, listed largest first by expense. Program spending in total: $12,229,452.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets and total liabilities at each year end, in dollars. The largest one-year move in total assets was 2023 to 2024, from $7.9M to $3.9M (−51%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
Government-grant reliance: 2017 22% · 2018 16% · 2019 31% · 2020 28% · 2021 53% · 2022 41% · 2023 38% · 2024 54%. Grants only. Government contracts and fees sit inside program revenue.
99% of AIDS VACCINE ADVOCACY COALITION INC’s revenue is contributions — more reliant on donations than three-quarters of its peers (21% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 8 reported years ran a deficit.
reserve
Leadership and staff
The officers, directors, trustees and key employees listed on each return. Joined and no longer listed compare each filing with the year before, matching people by surname and first initial; a year after a gap, or a roster under three people, has no comparison.
Chief executive
Mitchell Warren
Executive director
As listed on its FY2024 Form 990.
Who funds it, year by year
2017 → 2023: the base broadened from 4 funders to 11 funders, grant income fell $11M → $8.1M.
5 of 16 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 2% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of AIDS VACCINE ADVOCACY COALITION INC’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How concentrated its funding is
AIDS VACCINE ADVOCACY COALITION INC leans on a few funders — its largest provides 88% of grant income and the top three 96%; half comes from just 1 funder.
the vertical line marks half of all grant income — 1 funder to its left
Largest funder’s share by year: 2017 95% · 2018 94% · 2019 96% · 2020 95% · 2021 88% · 2022 77% · 2023 71% — diversifying over time.
“Effective funders” = inverse Herfindahl index (1 / Σ shareᵢ²) — the number of equal-sized funders that would give the same concentration. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
How long its funders stay
57% of AIDS VACCINE ADVOCACY COALITION INC's funders are still giving 3 years after their first grant; 69% give in more than one year at all.
Share of funders still giving k years after their first recorded grant, pooled across every acquisition cohort. A funder counts as retained in a year only if it made a grant that year. Measured to FY2023, the last fiscal year that has finished arriving — a funder cannot be counted as lapsed in a year most filers have not reached.
Where its funders are
AIDS VACCINE ADVOCACY COALITION INC draws 97% of its grant income from funders outside New York, across 6 states in all.
In-state vs out-of-state, by year
Funder states come from each funder’s own filing. $1.7M arriving through sponsors registered in 4 states is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
AIDS VACCINE ADVOCACY COALITION INC is better cushioned than half of the 3,288 human services nonprofits its size.
this organization peer median middle 50% of peers· 3,288 human services nonprofits $10M–$100M, FY2024
Government funding AIDS VACCINE ADVOCACY COALITION INC receives
Grants and contracts to this organization from federal (USASpending) and state checkbooks, reconciled to its EIN. $30.6M on record.
- Agency for International Development$30.6M
Federal grants vs contracts are distinguished; state line items keep their reported category. Matched by name + geography (the BMF), so coverage is partial and precision-first.
Organizations like AIDS VACCINE ADVOCACY COALITION INC
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New York
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Where the money goes
81% of spending goes to programs.
Governance
Public support
58%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Footprint & structure
Files a return copy in 1 state
Screen this organization
A dated, signed PDF of the compliance screen for AIDS VACCINE ADVOCACY COALITION INC: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds AIDS VACCINE ADVOCACY COALITION INC?
- AIDS VACCINE ADVOCACY COALITION INC (New York) receives grants from 16 organizations whose IRS filings report $72,547,415 to it, the largest being GATES FOUNDATION ($63,807,563). 11 of them have funded it in more than one year.
- How many funders does AIDS VACCINE ADVOCACY COALITION INC have?
- IRS filings report 16 organizations giving $72,547,415 in grants to AIDS VACCINE ADVOCACY COALITION INC, 11 of which have funded it in more than one year.
- Who is the largest funder of AIDS VACCINE ADVOCACY COALITION INC?
- GATES FOUNDATION is the largest funder on record, with $63,807,563 in grants. The full list of funders is on this page.
- How can an organization like AIDS VACCINE ADVOCACY COALITION INC find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New York. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2024 (financials across 2017–2024), and the filings of 16 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing